热门资讯> 正文
Theravance因收购Zymeworks而下调Jones评级
2026-06-30 02:36
- Jones Trading has downgraded Theravance Biopharma (TBPH) to hold from buy following the announcement earlier Monday that Zymeworks (ZYME) is acquiring the company in a $929M deal.
- Analyst Debanjana Chatterjee wrote that the transaction does not pose antitrust risk or should face additional bids.
- Chatterjee noted that the $17/share offer price is a 22% premium to Theravance's closing price on March 3, the day the company reported top-line phase 3 results for ampreloxetine in symptomatic neurogenic orthostatic hypotension (nOH) due to multiple system atrophy.
More on Theravance Biopharma
- Theravance Biopharma: A Special Situation With A 50-100% Likely Upside
- Zymeworks to pay $17/share for Theravance Biopharma in $929M deal
- Summers Value Fund adds TBPH, exits ADMA among Q1 moves
- Seeking Alpha’s Quant Rating on Theravance Biopharma
- Historical earnings data for Theravance Biopharma
推荐文章
港股周报 | 市场风格切换！存储、光通信股暴跌，科指反弹近6%；花旗称科网股估值极具吸引力；创新药、机器人概念飙涨
一周IPO | 史上最大ADR来袭！SK海力士或下周五登陆美股；16只新股即将上市！“今年最贵新股”鼎泰高科火热招股中
年中盘点 | 存储概念“强者恒强”！闪迪年内狂飙858%霸榜美股升幅Top10，康宁势将成为下半年最大黑马？
一周财经日历 | 美联储会议纪要重磅来袭；SK海力士拟7月10日登陆美股；智谱、MiniMax限售股将解禁
华盛早报 | 美股冰火两重天！道指狂飙近600点，存储却遭恐慌性抛售；“大空头”Burry唱空美股半导体面临30%回调
7月3日外盘头条：特朗普2025年交易逾2.1万笔 霍尔木兹海峡不复往日 微软计划8月推出Copilot全端整合产品
美股前瞻 | 美国6月非农大幅低于预期！纳指期货转涨至0.5%；马斯克称特斯拉机器人产线或已就绪；英伟达祭出AI工厂分成模式
华盛早报 | AI硬件股集体“熄火”！闪迪、美光暴跌10%，韩股开盘即熔断；苹果酝酿采购中国存储芯片
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
